ZA200205106B - Novel lipopeptides as antibacterial agents. - Google Patents

Novel lipopeptides as antibacterial agents.

Info

Publication number
ZA200205106B
ZA200205106B ZA200205106A ZA200205106A ZA200205106B ZA 200205106 B ZA200205106 B ZA 200205106B ZA 200205106 A ZA200205106 A ZA 200205106A ZA 200205106 A ZA200205106 A ZA 200205106A ZA 200205106 B ZA200205106 B ZA 200205106B
Authority
ZA
South Africa
Prior art keywords
antibacterial agents
novel lipopeptides
lipopeptides
novel
antibacterial
Prior art date
Application number
ZA200205106A
Other languages
English (en)
Inventor
Jason Hill
Michael Morytko
Xiang Yang Yu
Dennis Keith
Dale Christensen
Alan D Watson
Ian Parr
Jim Siedlecki
Jared Silverman
John Finn
Tsvetelina Lazarova
Zhang Yan
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of ZA200205106B publication Critical patent/ZA200205106B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200205106A 1999-12-15 2002-06-25 Novel lipopeptides as antibacterial agents. ZA200205106B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17094399P 1999-12-15 1999-12-15

Publications (1)

Publication Number Publication Date
ZA200205106B true ZA200205106B (en) 2003-09-25

Family

ID=22621910

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205106A ZA200205106B (en) 1999-12-15 2002-06-25 Novel lipopeptides as antibacterial agents.

Country Status (13)

Country Link
US (2) US6911525B2 (cg-RX-API-DMAC7.html)
EP (4) EP2298790A1 (cg-RX-API-DMAC7.html)
JP (2) JP4990456B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020063227A (cg-RX-API-DMAC7.html)
CN (1) CN1425025A (cg-RX-API-DMAC7.html)
AU (1) AU784755B2 (cg-RX-API-DMAC7.html)
BR (1) BR0017026A (cg-RX-API-DMAC7.html)
CA (1) CA2393907A1 (cg-RX-API-DMAC7.html)
IL (2) IL150223A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02006029A (cg-RX-API-DMAC7.html)
NO (1) NO20022888L (cg-RX-API-DMAC7.html)
WO (1) WO2001044272A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200205106B (cg-RX-API-DMAC7.html)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2394350A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
CA2301336A1 (en) * 2000-03-17 2001-09-17 Michael T. Kelly Topical treatment of rosacea
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
EP1343811A4 (en) 2000-12-18 2004-12-08 Cubist Pharm Inc METHOD FOR PRODUCING PURIFIED LIPOPEPTIDES
AU2002353775A1 (en) 2001-08-06 2003-03-10 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
EP1421093B1 (en) * 2001-08-28 2005-06-29 Pharmacia Corporation Crystaline clindamycin free base
US6767718B2 (en) 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
WO2003099217A2 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
WO2003103699A1 (en) 2002-06-06 2003-12-18 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
US20040132764A1 (en) * 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US20080051326A1 (en) * 2004-11-12 2008-02-28 Alexander Dylan C Antiinfective Lipopeptides
EP1814588A2 (en) * 2004-11-12 2007-08-08 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides
EP2974718A1 (en) * 2005-04-29 2016-01-20 Cubist Pharmaceuticals, Inc. Therapeutic compositions
US20100227918A1 (en) * 2006-04-26 2010-09-09 Taro Pharmaceuticals North America, Inc. Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria
WO2008014733A1 (de) * 2006-08-02 2008-02-07 Johannes Gutenberg-Universität Mainz Arzneimittel gegen lct-vergiftungen
US20080185010A1 (en) * 2007-02-06 2008-08-07 Kesselman Joshua D Interleaved Transparent Cellulose Paper with Opaque Adhesive
US8662086B2 (en) 2007-02-06 2014-03-04 BBK Tobacco & Foods, LLP Reclosable package with magnetic clasp for rolling papers used in smoking articles
US8584854B2 (en) * 2007-02-06 2013-11-19 BBK Tobacco & Foods, LLP Reclosable package with magnetic clasp and detachable tray for rolling papers used in smoking articles
US20090020443A1 (en) * 2007-05-09 2009-01-22 Kesselman Joshua D Credit Card Carrying Pack for Rolling Papers
US9072319B2 (en) 2007-06-15 2015-07-07 Joshua D. Kesselman Rolling paper structures for creating smoking articles and gummed, coiled inserts for same
US9161572B2 (en) * 2007-06-15 2015-10-20 Bbk Tobacco & Foods, Inc. Structures for creating smoking articles and methods of packaging same
US20090014342A1 (en) * 2007-07-14 2009-01-15 Kesselman Joshua D Rolling papers and methods of packaging same
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
CN101959849A (zh) * 2007-12-26 2011-01-26 利德治疗公司 作为抗菌剂的新型半合成糖肽
US8393332B2 (en) 2008-08-21 2013-03-12 BBK Tobacco & Foods, LLP Packaging for rolling papers for smoking articles
USD606858S1 (en) 2008-08-21 2009-12-29 Joshua Kesselman Packaging for smoking articles
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
EP2379580B1 (en) * 2008-12-22 2013-10-23 Cubist Pharmaceuticals, Inc. Novel antibacterial agents for the treatment of gram positive infections
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
ES2374779B1 (es) * 2010-03-10 2012-12-27 Universidad De Barcelona Compuestos péptidicos útiles como agentes antibacterianos.
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CA2806362A1 (en) * 2010-07-23 2012-01-26 Activbiotics Pharma, Llc Administration of rifalazil to immunocompromised patients
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
CN110577581A (zh) * 2018-06-07 2019-12-17 美国蓝博药业公司 一种新型的抑菌脂肽化合物、制备方法及其应用
CN109182563B (zh) * 2018-08-01 2020-07-14 浙江大学 检测20种dfrA类甲氧苄胺嘧啶类药物耐药基因的方法及所用试剂盒
CN113061164B (zh) * 2021-03-29 2023-01-10 四川大学 环脂肽类化合物及其在抗类风湿关节炎药物中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
IE55221B1 (en) 1982-02-27 1990-07-04 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
DK165416C (da) 1984-10-09 1993-04-05 Lilly Co Eli Fremgangsmaade til fremstilling af derivater af det antibiotisk virksomme cycliske peptid a-21978c
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
CA2043762C (en) * 1990-06-07 2001-05-29 Adam J. Kreuzman Lipopeptide deacylase
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
WO1995005384A1 (en) 1993-08-13 1995-02-23 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ES2379107T3 (es) 1996-03-08 2012-04-20 Astellas Pharma Inc. Procedimiento para la desacilación de lipopéptidos cíclicos
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
SI1115417T1 (sl) 1998-09-25 2006-08-31 Cubist Pharm Inc Uporaba daptomicina
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device

Also Published As

Publication number Publication date
EP1884520A2 (en) 2008-02-06
NO20022888L (no) 2002-08-02
WO2001044272A3 (en) 2001-11-29
EP2298790A1 (en) 2011-03-23
MXPA02006029A (es) 2004-08-23
EP1240181A2 (en) 2002-09-18
JP4990456B2 (ja) 2012-08-01
NO20022888D0 (no) 2002-06-17
US6911525B2 (en) 2005-06-28
EP2295444A2 (en) 2011-03-16
JP2003517004A (ja) 2003-05-20
US7335725B2 (en) 2008-02-26
WO2001044272A2 (en) 2001-06-21
AU784755B2 (en) 2006-06-08
BR0017026A (pt) 2003-01-07
CN1425025A (zh) 2003-06-18
AU2268201A (en) 2001-06-25
US20050203006A1 (en) 2005-09-15
EP1884520A3 (en) 2008-03-05
US20020025924A1 (en) 2002-02-28
KR20020063227A (ko) 2002-08-01
CA2393907A1 (en) 2001-06-21
IL150223A0 (en) 2002-12-01
EP2295444A3 (en) 2011-03-23
IL150223A (en) 2013-09-30
JP2012140432A (ja) 2012-07-26

Similar Documents

Publication Publication Date Title
ZA200205113B (en) Novel lipopeptides as antibacterial agents.
ZA200205106B (en) Novel lipopeptides as antibacterial agents.
IL150393A0 (en) 3-aminoquinazolin-2,4-dione antibacterial agents
ZA200201810B (en) Combined vaccine compositions.
ZA200300793B (en) Substituted-triazolopyrimidines as anticancer agents.
NO20022887L (no) Lipopeptider som antibakterielle midler
MXPA03009894A (es) Agentes antibacterianos.
MXPA01013312A (es) Composiciones antibacterianas.
AU3979200A (en) Antimicrobial agents
ZA200203486B (en) Novel pharmaceutical compositions.
HUP0202514A3 (en) Antibacterial agents
HUP0201795A3 (en) Disinfectants
ZA200105597B (en) Antibacterial composition.
MXPA02000261A (es) Aminoindanos novedosos.
AU5630800A (en) Antimicrobial agents
ZA200205108B (en) Lipopeptides as antibacterial agents.
GB9918869D0 (en) Antibacterial agents
ZA200201714B (en) Novel compound F-15078.
GB9922300D0 (en) Disinfectant composition
ZA992045B (en) Antibacterial agents.
GB9927093D0 (en) Antibacterial agents
GB9908874D0 (en) Antibacterial agents
GB9916973D0 (en) Antibacterial agents
GB9907981D0 (en) Antibacterial agents
GB9918984D0 (en) Antibacterial agents